# The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection

> **NCT01032655** · PHASE4 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 134 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** susceptibility test guided sequential therapy

## Key facts

- **NCT ID:** NCT01032655
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2012-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01032655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01032655, "The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01032655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*